Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$78.94
-0.9%
$79.04
$73.31
$132.29
$200.05B0.3813.14 million shs13.74 million shs
SOS Limited Unsponsored ADR stock logo
SOS
SOS
$5.70
+1.8%
$5.66
$4.04
$15.51
$17.51M2.0854,423 shs12,832 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-0.79%+0.60%+2.77%-8.97%-40.03%
SOS Limited Unsponsored ADR stock logo
SOS
SOS
-3.76%-3.84%-10.80%+19.68%-52.28%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.9978 of 5 stars
3.25.05.03.93.02.53.8
SOS Limited Unsponsored ADR stock logo
SOS
SOS
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.43
Hold$109.1938.32% Upside
SOS Limited Unsponsored ADR stock logo
SOS
SOS
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SOS, ZAMZ, G4M, and MRK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Cautious
5/14/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$115.00 ➝ $84.00
4/22/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$85.00
4/17/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$115.00 ➝ $115.00
(Data available from 6/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$64.17B3.09$9.37 per share8.42$18.33 per share4.31
SOS Limited Unsponsored ADR stock logo
SOS
SOS
$231.42M0.08N/AN/A$139.30 per share0.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$17.12B$6.8711.497.970.8327.27%43.23%17.11%7/29/2025 (Estimated)
SOS Limited Unsponsored ADR stock logo
SOS
SOS
-$13.60MN/A0.00N/AN/AN/AN/AN/A

Latest SOS, ZAMZ, G4M, and MRK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2025Q1 2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.16$2.22+$0.06$2.01$15.59 billion$15.53 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.244.10%N/A47.16%14 Years
SOS Limited Unsponsored ADR stock logo
SOS
SOS
N/AN/AN/AN/AN/A

Latest SOS, ZAMZ, G4M, and MRK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/27/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.814.18%6/16/20256/16/20257/8/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.69
1.41
1.16
SOS Limited Unsponsored ADR stock logo
SOS
SOS
N/A
9.97
9.97

Institutional Ownership

CompanyInstitutional Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
SOS Limited Unsponsored ADR stock logo
SOS
SOS
1.92%

Insider Ownership

CompanyInsider Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.13%
SOS Limited Unsponsored ADR stock logo
SOS
SOS
2.74%
CompanyEmployeesShares OutstandingFree FloatOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.51 billion2.51 billionOptionable
SOS Limited Unsponsored ADR stock logo
SOS
SOS
1703.13 million3.04 millionNo Data

Recent News About These Companies

SOS Limited Reports 2024 Financial Results
SOS Limited Delays Annual Report Filing
SOS Limited files $500M mixed securities shelf
SOS Limited (SOS)
SOS Limited rises 27.8%
SOS Limited rises 36.8%
SOS Limited rises 31.2%
SOS Limited rises 89.8%
SOS Limited rises 47.2%
SOS Stock Soars As Company Plans $50M Bitcoin Purchase

New MarketBeat Followers Over Time

Media Sentiment Over Time

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$78.94 -0.73 (-0.92%)
Closing price 03:59 PM Eastern
Extended Trading
$78.99 +0.05 (+0.07%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

SOS stock logo

SOS NYSE:SOS

$5.70 +0.10 (+1.79%)
Closing price 03:58 PM Eastern
Extended Trading
$5.88 +0.18 (+3.14%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SOS Limited provides data mining and analysis services to corporate and individual members in the People's Republic of China. It provides marketing data, technology, and solutions for insurance companies; emergency rescue services; and insurance product and health care information portals. The company operates SOS cloud emergency rescue service software as a service platform that offers basic cloud products, such as medical rescue, auto rescue, financial rescue, and life rescue cards; cooperative cloud systems, including information rescue center, intelligent big data, and intelligent software and hardware; and information cloud systems, such as newsToday and E-commerce Today, 10086 hot-line center, information security services, and marketing-related data. It also focuses on cryptocurrency mining, blockchain-based insurance, and security management businesses. The company serves insurance companies, financial institutions, medical institutions, healthcare providers, and other service providers in the emergency rescue services industry. The company is based in Qingdao, the People's Republic of China.